Banco de Sabadell’s GoHealth GOCO Stock Holding History

Banco de Sabadell’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-971	Closed	-$196K	–	330
2020 Q4	$196K	Buy	+971	New	+$180K	0.02%	235

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Banco de Sabadell's GOCO Position: Q1 2021 in Review

Banco de Sabadell sold out of GoHealth (GOCO) in Q1 2021, closing a stake of 971 shares — an estimated $196K sold.

Banco de Sabadell first reported a position in GOCO in Q4 2020 and held it in 1 quarter. The position peaked at $196K in Q4 2020. 109 funds tracked by Wall St. Rank hold GOCO as of Q1 2021.

Banco de Sabadell reported no remaining GoHealth position as of Q1 2021 after selling out during the quarter.
Banco de Sabadell sold 971 GoHealth shares in Q1 2021, an estimated $196K.
Banco de Sabadell first reported a position in GoHealth in Q4 2020 and held it in 1 quarter.
Banco de Sabadell's GoHealth position peaked at $196K in Q4 2020.
109 funds tracked by Wall St. Rank held GoHealth as of Q1 2021.

Based on Banco de Sabadell's 13F filing for Q1 2021, filed 14 May 2021.